Unravelling the relevance of CLEC12A as a cancer stem cell marker in myelodysplastic syndrome.

Br J Haematol · 2016 · PMC5091626 · PMID 27612176

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approaching significanceno p-value reported

Hence, although with a p‐value approaching significance in favour of a higher amount of CLEC12A expressing CD34 + CD38 − cells in CD34 + AML, in our cohort the level of this particular cell subset is seemingly comparable in MDS and CD34 + AML.

also in 2,640 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.